| Financial Year |
March 31 2023 |
| Monetary Funds |
19,476,283,930.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,340,715.71 |
| Accounts Receivable |
627,948,111.72 |
| Advances to Suppliers |
513,631,791.83 |
| Other Receivables |
629,665,513.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
342,256,788.49 |
| Inventories |
2,897,517,344.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
27,900,000.00 |
| Other Current Assets |
242,045,200.71 |
| Total Current Assets |
25,001,589,541.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,662,006,937.19 |
| Investment Properties |
237,359,028.37 |
| Fixed Assetes |
21,038,498,378.27 |
| Under-construction Projects |
1,048,743,702.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,180,096,742.53 |
| R&D expenses |
27,319,621.89 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
642,604,669.94 |
| Deferred Income Tax Assets |
819,795,565.27 |
| Other Non-Current Assets |
3,568,806,829.92 |
| Sub-Total of Non-Current Assets |
37,298,330,023.72 |
| Total Assets |
62,299,919,565.10 |
| Short-Term Loans |
21,890,146,416.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,571,931,450.00 |
| Accounts Payable |
2,882,378,860.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,037,381,713.19 |
| Taxes Payable |
607,467,698.88 |
| Interest Payable |
-- |
| Dividend Payable |
305,280,528.05 |
| Other payables |
2,983,045,697.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,123,755,951.20 |
| Other Current Liabilities |
87,931,356.91 |
| Sub-Total of Current Liabilities |
34,929,972,950.90 |
| Long-term Loans |
3,142,885,324.92 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
842,585,108.97 |
| Deferred Income Tax Liabilities |
245,483,333.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,442,881,865.90 |
| Total Liabilities |
39,372,854,816.80 |
| Paid-In Capital(Or Share Stock) |
2,250,986,609.00 |
| Capital Surplus |
2,662,266,861.68 |
| Surplus Reserve |
1,397,361,921.30 |
| LESS:Treasury Stock |
86,494,864.00 |
| Undistributed Profits |
11,063,222,770.98 |
| Minority Stockholder's Interest |
5,291,715,198.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,635,349,549.31 |
| Owner's Equity（Stockholder's Equity） |
22,927,064,748.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
62,299,919,565.10 |
